Analytical Data
-
Gene name
PLIN5
- Application
-
Alternative Names
LSDP5; LSDA5; OXPAT; PAT-1; MLDP; Lipid Storage Droplet Protein 5
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q00G26
-
Expression Region
Ile381~Phe463
-
Molecular Weight
15kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PLIN5 (Perilipin 5) is a lipid droplet-associated protein that plays a crucial role in regulating lipid metabolism and energy homeostasis in adipocytes and muscle cells. Research on PLIN5 has gained momentum due to its involvement in metabolic disorders such as obesity, diabetes, and cardiovascular diseases. As a member of the perilipin family, PLIN5 is integral in promoting lipid storage and mobilization, influencing mitochondrial function, and enhancing fatty acid oxidation. Its expression is often altered in various pathophysiological conditions, which raises interest in understanding its underlying mechanisms and potential therapeutic implications. The production of recombinant PLIN5 protein has enabled detailed studies on its structure, function, and interactions with other cellular components. These investigations are essential for elucidating the role of PLIN5 in lipid metabolism and developing strategies to target it for therapeutic purposes. By comprehensively studying PLIN5, researchers aim to unveil its potential as a biomarker for metabolic diseases and as a target for innovative therapies that could improve metabolic health and reduce the burden of associated diseases.
